Season 2 (2021-2030)

Cardiovascular - Peptide (1)

Modality Indication Targets Stage Company Project No. Detail
1 Nonclinical Development of PP1 Targeting Drug for Pulmonary Arterial Hypertension
Peptide Pulmonary hypertension PP1 Preclinical NadianBio HN21C1316
BACK